The Northeast region of the United States is approaching the annual respiratory syncytial virus (RSV) season. The onset ranges from November 2018 through March 2019. RSV is the most common cause of bronchiolitis and pneumonia among children younger than one year. During RSV season, AmeriHealth will approve the monthly administration of Synagis^? for children in accordance with the most recent recommendations from the American Academy of Pediatrics (AAP).

It is mandatory for all participating providers to obtain Synagis^? for AmeriHealth members through ACRO Pharmaceutical Services.

In October, detailed information about ordering Synagis^?, as well as the complete list of recommendations for Synagis^? from the AAP, will be communicated via Partners in Health Update^SM. If you have questions about the Synagis^? distribution program, please contact Customer Service at 1-888-YOUR-AH1 for AmeriHealth New Jersey or at 1-800-275-2583 for AmeriHealth Pennsylvania.

This is not a statement of benefits. Benefits may vary based on state requirements, Benefits Program (HMO, PPO, etc.), and/or employer groups. Providers should use the NaviNet^? web portal to view the member?s applicable benefits information. Members should be instructed to call the Customer Service telephone number listed on their ID card.

NaviNet is a registered trademark of NaviNet.